Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacogenetics of OPRM1
Richard C. Crist, Wade H. Berrettini
Pharmacology Biochemistry and Behavior (2013) Vol. 123, pp. 25-33
Open Access | Times Cited: 99

Showing 26-50 of 99 citing articles:

Pharmacogenomics and Patient Treatment Parameters to Opioid Treatment in Chronic Pain: A Focus on Morphine, Oxycodone, Tramadol, and Fentanyl
Renae A Lloyd, Elizabeth Hotham, Catherine Hall, et al.
Pain Medicine (2016) Vol. 18, Iss. 12, pp. 2369-2387
Open Access | Times Cited: 23
Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism
Elyse M. Cornett, Michelle A. Carroll Turpin, Allison Pinner, et al.
Current Oncology Reports (2020) Vol. 22, Iss. 2
Closed Access | Times Cited: 21
Endogenous opioid system: a promising target for future smoking cessation medications
Haval Norman, Manoranjan S. D’Souza
Psychopharmacology (2017) Vol. 234, Iss. 9-10, pp. 1371-1394
Closed Access | Times Cited: 22
Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study
Jordi Barrachina, César Margarit, Javier Muriel, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Neuromodulation in Parkinson’s disease targeting opioid and cannabinoid receptors, understanding the role of NLRP3 pathway: a novel therapeutic approach
Md Reyaz Alam, Shamsher Singh
Inflammopharmacology (2023) Vol. 31, Iss. 4, pp. 1605-1627
Closed Access | Times Cited: 6
Racial association and pharmacotherapy in neonatal opioid withdrawal syndrome
Abhinav Parikh, Mathangi Gopalakrishnan, Ahad Azeem, et al.
Journal of Perinatology (2019) Vol. 39, Iss. 10, pp. 1370-1376
Closed Access | Times Cited: 19
Combining Human and Rodent Genetics to Identify New Analgesics
Alban Latrémolière, Michael Costigan
Neuroscience Bulletin (2017) Vol. 34, Iss. 1, pp. 143-155
Open Access | Times Cited: 17
Effects of fentanyl administration on locomotor response in horses with the G57C μ-opioid receptor polymorphism
Lois A. Wetmore, Peter J. Pascoe, Yael Shilo‐Benjamini, et al.
American Journal of Veterinary Research (2016) Vol. 77, Iss. 8, pp. 828-832
Closed Access | Times Cited: 16
Urine drug testing results and paired oral fluid comparison from patients enrolled in long-term medication-assisted treatment in Tennessee
Katie Miller, Brandi L. Puet, Ali Roberts, et al.
Journal of Substance Abuse Treatment (2017) Vol. 76, pp. 36-42
Closed Access | Times Cited: 16
Methadone’s effect on nAChRs—a link between methadone use and smoking?
Reeta Talka, Raimo K. Tuominen, Outi Salminen
Biochemical Pharmacology (2015) Vol. 97, Iss. 4, pp. 542-549
Closed Access | Times Cited: 15
Buprenorphine: prospective novel therapy for depression and PTSD
Caitlin A. Madison, Shoshana Eitan
Psychological Medicine (2020) Vol. 50, Iss. 6, pp. 881-893
Closed Access | Times Cited: 14
Naltrexone Use in Treating Hypersexuality Induced by Dopamine Replacement Therapy: Impact of OPRM1 A/G Polymorphism on Its Effectiveness
Audrey Verholleman, Caroline Victorri‐Vigneau, Edouard‐Jules Laforgue, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 3002-3002
Open Access | Times Cited: 14
Involvement of CYP2D6 and CYP2B6 on Tramadol Pharmacokinetics
Miriam Saiz‐Rodríguez, Dolores Ochoa, Manuel Román, et al.
Pharmacogenomics (2020) Vol. 21, Iss. 10, pp. 663-675
Closed Access | Times Cited: 13
Opioid Receptor-Mediated and Non-Opioid Receptor-Mediated Roles of Opioids in Tumour Growth and Metastasis
Claudia A. Scroope, Zane Singleton, Markus W. Hollmann, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 12
Opioid-related genetic polymorphisms do not influence postoperative opioid requirement
Frédéric Aubrun, Noël Zahr, Olivier Langeron, et al.
European Journal of Anaesthesiology (2018) Vol. 35, Iss. 7, pp. 496-504
Open Access | Times Cited: 14
The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review
Bilel Oueslati, O. Moula, Rim Ghachem
Pharmacogenomics (2018) Vol. 19, Iss. 8, pp. 741-747
Closed Access | Times Cited: 14
GPCR and Alcohol-Related Behaviors in Genetically Modified Mice
Jérémie Neasta, Emmanuel Darcq, Jérôme Jeanblanc, et al.
Neurotherapeutics (2020) Vol. 17, Iss. 1, pp. 17-42
Open Access | Times Cited: 12
Insights into the mechanisms underlying opioid use disorder and potential treatment strategies
Danni Cao, Fēi Li, Ning Wu, et al.
British Journal of Pharmacology (2021) Vol. 180, Iss. 7, pp. 862-878
Open Access | Times Cited: 11
Association of OPRM1, MIR23B, and MIR107 genetic variability with acute pain, chronic pain and adverse effects after postoperative tramadol and paracetamol treatment in breast cancer
Zala Vidic, Katja Goričar, Branka Stražišar, et al.
Radiology and Oncology (2023) Vol. 57, Iss. 1, pp. 111-120
Open Access | Times Cited: 4
OPRM1 and BDNF polymorphisms associated with a compensatory neurophysiologic signature in knee osteoarthritis patients
Fernanda de Toledo Gonçalves, Lucas Murrins Marques, Anne Victório Pessotto, et al.
Neurophysiologie Clinique (2023) Vol. 53, Iss. 6, pp. 102917-102917
Closed Access | Times Cited: 4
Potential influence of different peri-operative analgesic regimens on tumour biology and outcome after oncologic surgery
Lucillia Bezu, Patrice Forget, Markus W. Hollmann, et al.
European Journal of Anaesthesiology (2024)
Closed Access | Times Cited: 1
Influence of Genetic Polymorphisms on the Response to Tramadol, Ibuprofen, and the Combination in Patients With Moderate to Severe Pain After Dental Surgery
Miriam Saiz‐Rodríguez, Sarahí Valdez-Acosta, Alberto M. Borobia, et al.
Clinical Therapeutics (2021) Vol. 43, Iss. 5, pp. e86-e102
Closed Access | Times Cited: 10
A Genetic Assessment of Dopamine Agonist-Induced Impulse Control Disorder in Patients With Prolactinoma
Serdar Şahin, Tuğçe Sudutan, Yasin Kavla, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 108, Iss. 6, pp. e275-e282
Closed Access | Times Cited: 7
A6V polymorphism of the human μ‐opioid receptor decreases signalling of morphine and endogenous opioids in vitro
Alisa Knapman, Marina Santiago, Mark Connor
British Journal of Pharmacology (2014) Vol. 172, Iss. 9, pp. 2258-2272
Open Access | Times Cited: 10
Overview of Genetic Analysis of Human Opioid Receptors
Santi Spampinato
Methods in molecular biology (2014), pp. 3-12
Closed Access | Times Cited: 9

Scroll to top